During last decade, pharmacogenomics has gained a huge attention in the treatment of the diseases such as cancer, diabetes, genetic diseases and others. Personalized medicines are manufactured according to the safety requirement of the patient or group of patients. The global personalized medicines market is majorly driven by increasing prevalence of cancer, and other chronic diseases, rapid development in the healthcare sector and increasing need for the better treatment options. More
